Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Boras – page 3

50 clinical trials in Boras, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Boras at a glance
50
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

50 trials in Boras

Open in trial search
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Psoriasis

Not recruiting
Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Dyslipidaemia

Not recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Breast cancer

Not recruiting
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Recombinant Varicella Zoster Virus Glycoprotein E
  • Sponsor:GlaxoSmithKline Biologicals

Type 2 diabetes mellitus+1

Not recruiting
Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity

Not recruiting
Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Celgene Corp.
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Pfizer Inc.
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Betamethasone Sodium Phosphate
  • Sponsor:Uppsala Universitet
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Sweden

The busiest research cities in the country

All 65 cities in Sweden

Clinical research in Boras

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on breast cancer treatments, including trials for HR+/HER2- variants and triple-negative cases. Additional research examines innovative therapies for lymphocytic leukemia and prostate cancer.

  • Advanced breast cancer treatments
  • Leukemia therapy optimization
  • Metastatic cancer management

Multiple trials are evaluating novel drug combinations and targeted therapies to improve patient outcomes.

02 Immunology & Vaccines

Research investigating immune responses in pediatric cancer patients post-vaccination against measles and chickenpox. Studies also examine long-term efficacy of Herpes Zoster vaccines in older adults.

  • Pediatric vaccination studies
  • Immune response assessment
  • Vaccine effectiveness research

Focus on developing robust immunity in vulnerable populations.

03 Metabolic Disorders

Clinical trials examining new treatments for obesity and Type 2 diabetes. Studies evaluate medication effectiveness combined with lifestyle modifications for weight management.

  • Weight management therapies
  • Diabetes treatment optimization
  • Metabolic health interventions

Innovative approaches to treating complex metabolic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.